Bio-Techne (TECH) Cash from Investing Activities (QoQ) (2009 - 2026)
Bio-Techne (TECH) Cash from Investing Activities (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.27 Bn | 467.47 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.18 Bn | 114.93 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.08 Bn | 61.32 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn |
| 10 | Bio-Techne | 11.21 Bn | 11.00 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.76% |
| Dec 31, 2025 | -1,078.68% |
| Sep 30, 2025 | 49.01% |
| Jun 30, 2025 | 104.58% |
| Mar 31, 2025 | -76.33% |
| Dec 31, 2024 | 76.79% |
| Sep 30, 2024 | -146.19% |
| Jun 30, 2024 | 46.43% |
| Mar 31, 2024 | 30.54% |
| Dec 31, 2023 | 84.64% |
| Sep 30, 2023 | -3,140.33% |
| Jun 30, 2023 | 98.03% |
| Mar 31, 2023 | -221,088.99% |
| Dec 31, 2022 | 99.45% |
| Sep 30, 2022 | -6.02% |
| Jun 30, 2022 | 48.41% |
| Mar 31, 2022 | -2.35% |
| Dec 31, 2021 | -393.93% |
| Sep 30, 2021 | 96.86% |
| Jun 30, 2021 | -175,993.80% |